Lavo Life Sciences
DefunctYC W23Founded 2022 · 3 employees · 3 known investors
Find your way into Lavo Life Sciences
622 people in our graph share verified history with the Lavo Life Sciences team — schools, employers, funds. One of them is your warm intro.
Annie Kadavyunlockedknows Scott Swarthout · together at DoorDash (overlapped)
knows the team · via DoorDash
×10knows the team · via Y Combinator
Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.
Founders & leadership· Y Combinator alumni (W23)
Lavo Life Sciences was founded in 2022 by Scott Swarthout, Zach Glick, and Derek Metcalf.
SS
Scott SwarthoutinCEO, Co-Founder (Acquired by Dayhoff Labs)2022–2025Scott Swarthout is the founder and CEO of Lavo Life Sciences, which provides computational molecular simulation services to pharmaceutical companies.
ZG
Zach GlickinCTO, Co-founder2023–2025
Investors · 3
In the news
Frequently asked questions
- What does Lavo Life Sciences do?
- Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.
- Who founded Lavo Life Sciences?
- Lavo Life Sciences was founded by Scott Swarthout, Zach Glick, Derek Metcalf in 2022.
- Who are Lavo Life Sciences's investors?
- Lavo Life Sciences's investors include Eastlink Capital Partners, Undeterred Capital, Y Combinator.